We are pleased to report that Dr Katarzyna Magiera-Mularz of the Faculty of Chemistry at Jagiellonian University, a laureate of the 2018 START programme of the Foundation for Polish Science, has won the Prof. Wacław Szybalski Award of the Committee of Biotechnology of the Polish Academy of Sciences for the best original work by a young Polish researcher in the field of biotechnology published in 2017.
The work appeared in the prestigious journal Angewandte Chemie. The article for the first time characterized the molecular purpose of macrocyclic-peptide inhibitors directed at the PD-1/PD-L1 pathway (programmed cell death) and obtained information on how they function with PD-L1 protein. The results published in the award-winning article make an important contribution to the development of PD-L1 inhibitors with potential applications in immunotherapy, the most promising of recently developed anticancer strategies.
The Prof. Wacław Szybalski Award has been given by the Committee of Biotechnology of the Polish Academy of Sciences (PAN) since 2013 for the best experimental work in the field of biotechnology in a Polish laboratory by a young researcher, published in the year preceding the award in an indexed Polish or foreign journal. In addition to a citation, the laureate receives a cash prize of PLN 20,000 and is invited to present the paper at a session of the PAN Committee of Biotechnology.
Read the prize-winning article HERE
(Katarzyna Magiera-Mularz et al. (2017), “Bioactive macrocyclic inhibitors of the PD-1/PD-L1 immune checkpoint,” Angew. Chem. Int. Ed. DOI: 10.1002/anie.201707707)
Photo by OneHD